Advertisement
Advertisement
U.S. markets open in 6 hours 10 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Virpax Pharmaceuticals, Inc. (VRPX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.7600-0.4000 (-9.62%)
At close: 04:00PM EST
3.7700 +0.01 (+0.27%)
After hours: 07:55PM EST
Advertisement
Sign in to post a message.
  • F
    FEDERICO
    Enough of the flat line, gap fully close.

    Undervalue small cap low float with great value adding catalysts. Time for a pop and uptrend to close that gap up in the $9.75 area. And why not put another massive run and print a new 552 week high at over $36. That is less than 400 million market cap. And I think we have a nice value adding early pipeline with huge billion dollar markets to take on.

    Great risk/reward investment

    Onward and Upward

    Blessings
  • B
    Big chungus
    When can we see the catalyst
  • B
    BullRun
    This can moon next week! COVID antiviral spray you can buy at any convenience store!
  • S
    Steven
    Next big low float biotech runner. Check the presentation. Going for a partner/sublicense/white label of COVID anti-viral spray for OTC use. If successful, its a blockbuster! PT $10+++ soon
    Bullish
  • G
    Gold
    Big news about vrpx
    Bullish
  • B
    BigNims
    Big News coming up Tomorrow, Hold Hold ....
  • s
    sns
    The highest in 30 years inflation number is causing a lot of pain. I think I'll buy some more of that pain reliever co, VRPX. Plus with all this inflation, VRPX will be able to raise all expected market prices.
    Bullish
  • A
    Andy
    This stock can explode everytime in one day to 10$. Iam ready. At this price level you can accumulate. What is your opinion?
    Bullish
  • s
    sns
    VRPX short/bears scored a huge gain. Pocketing 95% of the gain from FDA new drug approval. $36 to $6.
    Pigs squeezed another $2 out of the trade to a little under $4. It's been a good 12 week run for the shorts.
    But I suspect the pigs r starting down the chute to the packing plant. Predicting big run up for VRPX to $12.
    Bullish
  • F
    Francesco
    Good morning everybody!
    I am searching some real data: but it's hard to find.
    Does anyone know how many partecipants were in the clinical study before Fda approval?

    Thx all
    Bullish
  • A
    Aaron
    I keep hearing how overvalued the stock market is, but in reality, most stocks are way down in 2021. The market concentration of the top 10 stocks is higher than it has been in a very long time. Last year, the top ten stocks accounted for ~18% of the total market cap. In 2015, that % was less than 15%. This year the top ten stocks represent roughly 30% of the total valuation of the entire stock market!

    Look at today even...Dow is down 30 bps while other indices are off 200 bps. This discrepancy has been happening for a long time now. I don't know if I am trying to be optimistic about my holdings, but I feel like a lot of stocks have already experienced major corrections this year, but no one talks about it because the Dow is at all time highs due to extreme overvaluations of the top 10 stocks...Amazon, Tesla, etc.

    Anyways, just my 2 cents. Not saying we aren't in for more pain, but I do believe at these levels stocks like VRPX have real upside value when viewing from a 2-3 year window. While if you look at the Teslas how could one think they will just continue to grow for the next 2-3 years when they are already outrageously overvalued relative to earnings. GLTA
  • s
    sns
    Switching to contrary. Buying the low while others lock-in losses, for tax purposes of course. Low prices all over the market not just here.
    Bullish
  • H
    H
    Fuel is burning underneath...
  • A
    Aaron
    Getting ridiculous at this point how polarized the market has become. Many stocks like this trading way below cash while you have Lucid type stocks trading at values that are way beyond anything justifiable. Not sure how this corrects itself, but this can't last forever.
  • s
    sns
    The next new news will probably be the Quarterly financial report for 9/30/21. I don't expect VRPX had any revenue, So the income statement isn't that important. It's the Balance Sheet that will tell cash on hand and the rest of numbers needed to calculate the burn rate. VRPX may just release in a SEC filing when it's ready or maybe announce a release date. Either way we should know sometime in the next few weeks.
    Bullish
  • s
    sns
    Back-n-fill. Looks good to me.
    Bullish
  • P
    PharmaExpert
    $IFRX conversation
    $CALA Q4 play with catalysts ahead;

    ✅2 significant data catalysts coming up in Q4 (which started yesterday);

    ✅$80M cash / no debt / low cash burn

    (Analysts are on $CALA for Keapsake data giving >100% upside potential on interim study results Q4) $25B market for NSCLC

    (Also new Phase 1b interim data to be presented at North American Cystic Fibrosis conference Nov 2-5) $8B market for CB

    ✅Licensed their CD73 with Antengene earlier this year - Calithera will receive an upfront payment and potential development, regulatory and sales milestones of up to $255.0 million.

    $CRVS ran 277% earlier this month after AstraZeneca CD73 Success, as it’s the only baby bio with CD73 that isn’t partnered...

    ✅Consolidation on chart for 6 months now, with significant catalysts ahead $2.50 break needed for a bigger move

    ✅Per 8-k in September 2021; they reached a Settlement agreement with Incyte - who will pay $CALA for missing 2 milestone payments after a licensing deal signed in 2017

    ✅Good Tutes like BVF, Primecap Management, and Adage all hold.

    ✅(BVF disclosed ownership of 7,452,331 shares in July an increase of 70% from their February 2021 filing to become 10% owner / major shareholder)

    BVF was the main institution behind the $FPRX turnaround last year which went from $4s ~> $38 in a $1.9B Buyout by Amgen after a bidding war

    $VRPX $PROG $CCXI
    Bullish
  • B
    BigNims
    https://ca.finance.yahoo.com/news/trade-alert-chairman-ceo-virpax-130457240.html

    Investors who take an interest in Virpax Pharmaceuticals, Inc. ( NASDAQ:VRPX ) should definitely note that the Chairman...
  • A
    Andy
    good buy oppertunity, Company is heavily underpriced and has a great product pipeline ..STRONG BUY
    Bullish
  • A
    Andy
    Why is this stock every day red? Totally undervalued and oversold.. STRONG buy
    Bullish
Advertisement
Advertisement